Marialena Mouzaki is a Gastroenterology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 135 publications with 5,881 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3333 Burnet Ave
Ml 2010
Cincinnati, OH 452293026
Telephone
513-636-4415Registry record last updated 19 Oct 2018.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- Mirum Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Biguanide (metformin)100%Metformin Hcl Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease
Cincinnati Childrens Hosp Med Ctr
FY2026$569,533R01DK133198 - Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease
Cincinnati Childrens Hosp Med Ctr
FY2025$639,629R01DK133198 - Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease
Cincinnati Childrens Hosp Med Ctr
FY2024$626,121R01DK133198
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
Frontiers in Pharmacology
2023 - Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
Clinical Gastroenterology and Hepatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Rothenberg, MD
Cincinnati Children's Hospital Medical Center
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Stuart Goldstein, MD
Cincinnati Children's Hospital Medical Center
Andrew Redington
Cincinnati Children's Hospital Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”